Advertisement

Sharon Bio-Medicine profit decreased 65.38% in (Q3) FY 2019-20

Source: 
Team Infinities:

Sharon Bio-Medicine Limited NSE Symbol:SHARONBIO, BSE Security Code:532908 has declared its 3rd(third) quarter un-audited Standalone financial report from the month of October, 2019 to the month of December, 2019; for the fiscal year 2019-20.

Revenue Reported by Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
3997.65 4258.81 3163.50 12671.51 10607.92
Calculated Revenue of Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
261.16 6.13%(Revenue Decrease) 834.15 26.37%(Revenue Increase) 2063.59 19.45%(Revenue Increase)

Revenue: Sharon Bio-Medicine Limited's financial report shows that the company's revenue decreased by 6.13% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for revenue decrease of Rs.261.16 lacs, as the company posted revenue of Rs.3997.65 lacs; in compare to previous quarter(July, 2019 - September, 2019) when the company reported revenue of Rs.4258.81 lacs.
The result also shows that the company's revenue increased by 26.37% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for revenue increase of Rs.834.15 lacs; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted revenue of Rs.3163.50 lacs.
The company also reported that its revenue increased by 19.45% in 9 months end(April, 2019 - December, 2019) for revenue increase of Rs.2063.59 lacs, since the company reported revenue of Rs.12671.51 lacs; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted revenue of Rs.10607.92 lacs.

Gross Margin(%) Reported by Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
58.52 36.69 4.28 49.07 32.61
Calculated Gross Margin(%) of Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
21.83 59.51%(GM Increase) 54.24 1268.83%(GM Increase) 16.46 50.49%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 59.51% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for 21.83% GM increase, as the company reported 58.52% GM; in compare to previous quarter(July, 2019 - September, 2019) when the company reported 36.69% GM.
The result also indicates, the company's GM increased by 1268.83% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for 54.24% GM increase; in compare to corresponding quarter(October, 2018 - December, 2018) when the company reported 4.28% GM.
The company also reported that its GM increased by 50.49% in 9 months end(April, 2019 - December, 2019) for 16.46% GM increase, since the company reported 49.07% GM; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company reported 32.61% GM.

EBITDA Reported by Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
568.46 697.96 274.33 4128.36(Negative) 1576.15
Calculated EBITDA of Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
129.50 18.55%(EBITDA Decrease) 294.13 107.22%(EBITDA Increase) 5704.51 361.93%(EBITDA Decrease)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 18.55% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for EBITDA decrease of Rs.129.50 lacs, as the company posted EBITDA of Rs.568.46 lacs; in compare to previous quarter(July, 2019 - September, 2019) when the company reported EBITDA of Rs.697.96 lacs.
The result also shows that the company's EBITDA increased by 107.22% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for EBITDA increase of Rs.294.13 lacs; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted EBITDA of Rs.274.33 lacs.
The company also reported that its EBITDA decreased by 361.93% in 9 months end(April, 2019 - December, 2019) for EBITDA decrease of Rs.5704.51 lacs, since the company reported Negative EBITDA of Rs.4128.36 lacs; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted EBITDA of Rs.1576.15 lacs.

Profit and Loss Reported by Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
158.73(Profit ) 458.51(Profit ) 3.38(Loss ) 5001.74(Loss ) 754.44(Profit )
Calculated Profit and Loss of Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
299.78 65.38%(Profit Decrease) 162.11 4796.15%(Profit Increase) 5756.18 762.97%(Loss Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 65.38% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for profit decrease of Rs.299.78 lacs, as the company posted profit of Rs.158.73 lacs; in compare to previous quarter(July, 2019 - September, 2019) when the company reported profit of Rs.458.51 lacs.
The result also shows that the company's profit increased by 4796.15% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for profit increase of Rs.162.11 lacs; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted loss of Rs.3.38 lacs.
The company also reported that its loss increased by 762.97% in 9 months end(April, 2019 - December, 2019) for loss increase of Rs.5756.18 lacs, since the company reported loss of Rs.5001.74 lacs; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted profit of Rs.754.44 lacs.

EPS Reported by Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
0.13 0.39 0.00 1.80(Negative) 0.63
Calculated EPS of Sharon Bio-Medicine Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
0.26 66.67%(EPS Decrease) 0.13 0.00%(EPS Increase) 2.43 385.71%(EPS Decrease)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 66.67% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for EPS decrease of Rs.0.26, as the company posted EPS of Rs.0.13; in compare to previous quarter(July, 2019 - September, 2019) when the company reported EPS of Rs.0.39.
The result also shows that the company's EPS increased by 0.00% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for EPS increase of Rs.0.13; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted EPS of Rs.0.00.
The company also reported that its EPS decreased by 385.71% in 9 months end(April, 2019 - December, 2019) for EPS decrease of Rs.2.43, since the company reported Negative EPS of Rs.1.80; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted EPS of Rs.0.63.



***All amounts are given in Lac Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

Add new comment

Comment Editor

  • No HTML tags allowed.
CAPTCHA
Please verify you are a human